ArticleAntimicrobial agents and chemotherapy2004
Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.
Article in Antimicrobial agents and chemotherapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 167 citations in OpenAlex.
- Molecular Characteristics and Factors Associated with Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial resistance patterns of Campylobacter jejuni isolated from retail raw chicken meat in Jordan.Poultry science · 2025Article
- The Global Challenge ofTropical medicine and infectious disease · 2025Review
- Genetic Diversity, Virulence, and Antibiotic Resistance Determinants ofPathogens (Basel, Switzerland) · 2024Article
- Spatiotemporal variations in the occurrence ofHeliyon · 2024Article
- Overview of Ecology and Aspects of Antibiotic Resistance inMicroorganisms · 2024Article
- Campylobacter jejuni and Campylobacter coli in human stool samples: antibiotic resistance profiles, putative virulence determinants and molecular characterization of the isolates.World journal of microbiology & biotechnology · 2023Article
- Assessing antimicrobial resistance inEpidemiology and infection · 2023Article
- The Genetic Diversity and Antimicrobial Resistance of Pyogenic Pathogens Isolated from Porcine Lymph Nodes.Antibiotics (Basel, Switzerland) · 2023Article
- Low-Level Tetracycline Resistance GeneAntibiotics (Basel, Switzerland) · 2023Article
- Genotypic characterization, antimicrobial susceptibility and virulence determinants ofFrontiers in microbiology · 2023Article
- Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens.Gut pathogens · 2022Article
- Relationships between Virulence Genes and Antibiotic Resistance Phenotypes/Genotypes inFoods (Basel, Switzerland) · 2022Article
- Tetracycline, Macrolide and Lincosamide Resistance inAntibiotics (Basel, Switzerland) · 2022Article
- Should We Consider Them as a Threat? Antimicrobial Resistance, Virulence Potential and Genetic Diversity ofAntibiotics (Basel, Switzerland) · 2022Article
- Resistome Analysis ofMicroorganisms · 2022Article
- Investigation of Antimicrobial Susceptibilities and Resistance Genes ofIranian journal of public health · 2022Article
- Genomic diversity and antimicrobial resistance of Campylobacter spp. from humans and livestock in Nigeria.Journal of biomedical science · 2022Article
- Prevalence and antimicrobial resistance ofCurrent research in food science · 2022Article
- Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Of 203 human clinical isolates of Campylobacter jejuni from Alberta, Canada (1999 to 2002), 101 isolates (50%) were resistant to at least 64 microg of tetracycline/ml, with four isolates exhibiting higher levels of tetracycline resistance (512 microg/ml). In total, the MICs for 37% of tetracycline-resistant isolates (256 to 512 microg/ml) were higher than those previously reported in C. jejuni (64 to 128 microg/ml). In the tetracycline-resistant clinical isolates, 67% contained plasmids and all contained the tet(O) gene. Four isolates resistant to high levels of tetracycline (MIC = 512 microg/ml) contained plasmids carrying the tet(O) gene, which could be transferred to other isolates of C. jejuni. The tetracycline MICs for transconjugants were comparable to those of the donors. Cloning of tet(O) from the four high-level tetracycline-resistant isolates conferred an MIC of 32 microg/ml for Escherichia coli DH5alpha. In contrast, transfer to a strain of C. jejuni by using mobilization conferred an MIC of 128 microg/ml. DNA sequence analysis determined that the tet(O) genes encoding lower MICs (64 to 128 microg/ml) were identical to one other, although the tet(O) genes encoding a 512-microg/ml MIC demonstrated several nucleotide substitutions. The quinolone resistance determining region of four ciprofloxacin-resistant isolates (2%) was analyzed, and resistance was associated with a chromosomal mutation in the gyrA gene resulting in a Thr-86-Ile substitution. In addition, six kanamycin-resistant isolates contained large plasmids that carry the aphA-3 marker coding for 3'-aminoglycoside phosphotransferase. Resistance to erythromycin was not detected in 203 isolates. In general, resistance to most antibiotics in C. jejuni remains low, except for resistance to tetracycline, which has increased from about 8 to 50% over the past 20 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.